Centre hospitalier régional et universitaire de Besançon (CHRU Besancon)


Standort der Organisation:
Besançon, Frankreich

Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern

Potorac, I., Petrossians, P., Daly, A.F., Alexopoulou, O., Borot, S., Sahnoun-Fathallah, M.,... Beckers, A. (2016). T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly. Endocrine-Related Cancer, 23(11), 871-881. https://dx.doi.org/10.1530/ERC-16-0356
Johansen, J.D., Aalto-Korte, K., Agner, T., Andersen, K.E., Bircher, A., Bruze, M.,... Uter, W. (2015). European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis, 73(4), 195-221. https://dx.doi.org/10.1111/cod.12432
Kramar, A., Negrier, S., Sylvester, R., Joniau, S., Mulders, P., Powles, T.,... Filleron, T. (2015). Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project+. Annals of Oncology, 26(12), 2392-8. https://dx.doi.org/10.1093/annonc/mdv380
Valentini, V., Van Stiphout, R.G.P.M., Lammering, G., Gambacorta, M.A., Barba, M.C., Bebenek, M.,... Lambin, P. (2015). Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer. Radiotherapy and Oncology, 114(3), 302-9. https://dx.doi.org/10.1016/j.radonc.2015.02.001

Zuletzt aktualisiert 2016-22-04 um 08:09